chr9-136410688-C-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_015160.3(PMPCA):c.20C>A(p.Ala7Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0133 in 1,414,204 control chromosomes in the GnomAD database, including 155 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A7T) has been classified as Uncertain significance.
Frequency
Consequence
NM_015160.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PMPCA | NM_015160.3 | c.20C>A | p.Ala7Glu | missense_variant | 1/13 | ENST00000371717.8 | |
PMPCA | XM_005266059.4 | c.20C>A | p.Ala7Glu | missense_variant | 1/12 | ||
PMPCA | NM_001282944.2 | c.-279C>A | 5_prime_UTR_variant | 1/12 | |||
PMPCA | NM_001282946.2 | c.-279C>A | 5_prime_UTR_variant | 1/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PMPCA | ENST00000371717.8 | c.20C>A | p.Ala7Glu | missense_variant | 1/13 | 1 | NM_015160.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0126 AC: 1914AN: 152186Hom.: 16 Cov.: 33
GnomAD3 exomes AF: 0.0135 AC: 1632AN: 121318Hom.: 20 AF XY: 0.0133 AC XY: 915AN XY: 68544
GnomAD4 exome AF: 0.0134 AC: 16941AN: 1261900Hom.: 139 Cov.: 31 AF XY: 0.0132 AC XY: 8182AN XY: 619766
GnomAD4 genome AF: 0.0126 AC: 1913AN: 152304Hom.: 16 Cov.: 33 AF XY: 0.0137 AC XY: 1018AN XY: 74474
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | PMPCA: BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
PMPCA-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 08, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at